No mutations but only benign polymorphisms were identified, most likely due to the small sample size, the low stringency of the selection criteria and the lack of complete analysis of BRCA2. Up to date no other surveys on BRCA1/2 mutations in Bulgarian patients with familial BC/OC have been published. The gene discussed is BRCA2; the disease is breast cancer.